The latest announcement is out from Medifast (MED).
At Medifast Inc.’s 2024 Annual Meeting, stockholders approved a significant update to the company’s Share Incentive Plan, increasing the stock authorization by 515,000 shares and implementing changes to its vesting provisions and director award limits. Additionally, all nominated directors were re-elected, RSM US LLP was ratified as the independent accounting firm for the fiscal year, and executive compensation received advisory approval. These decisions reflect the stockholders’ active involvement in shaping the company’s strategic incentive structures and governance.
See more insights into MED stock on TipRanks’ Stock Analysis page.
